Screener / SEC EDGAR /CIK 0001046257 /10-K filed Feb 17, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer staples · Packaged Foods

Ingredion Inc INGR

Compare with peers Embed
What it said it expected, against what it reported

4 targets with a reported result

Releases of the last 3 years
Above the range 1 above the last range given
Within the range 1 of 4 range targets
Below the range 2 below the last range given

The numbers INGR said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
Capital expenditures
Fiscal 2026
Given $400.00M to $440.00M release May 5, 2026
Raised $450.00M to $490.00M release Aug 4, 2026
Kept $450.00M to $490.00M release Nov 5, 2026
– Not reported yet
The company's words
Capital expenditures for the full year are expected to be approximately $400 to $440 million. release May 5, 2026
Capital expenditures for the full year are now expected to be approximately $450 to $490 million. release Aug 4, 2026
Capital expenditures for the full year are still expected to be approximately $450 to $490 million. release Nov 5, 2026
Diluted EPS
Fiscal 2026
Given $9.60 to $10.30 release May 5, 2026
Lowered $9.15 to $9.75 release Aug 4, 2026
Lowered $8.04 to $8.49 release Nov 5, 2026
– Not reported yet
The company's words
Adjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 release May 5, 2026
Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 release Aug 4, 2026
Adjusting full-year guidance for reported diluted EPS to be in the range of $8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70 release Nov 5, 2026
Diluted EPS (company-defined)
Fiscal 2026
Given $10.45 to $11.15 release May 5, 2026
Lowered $10.30 to $10.90 release Aug 4, 2026
Lowered $9.25 to $9.70 release Nov 5, 2026
– No standard number
The company's words
Adjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 release May 5, 2026
Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 release Aug 4, 2026
Adjusting full-year guidance for reported diluted EPS to be in the range of $8.04 to $8.49 and adjusted diluted EPS to be in the range of $9.25 to $9.70 release Nov 5, 2026
Capital expenditures
Fiscal 2025 (ended Dec 31, 2025)
Given $400.00M to $450.00M release Feb 4, 2025
Lowered $400.00M to $425.00M release Aug 1, 2025
Kept $400.00M to $425.00M release Nov 4, 2025
$433.00M
10-K filed 2026-02-17
Above the range
The company's words
2025 Full-Year Outlook … Capital expenditures for the full year are expected to be approximately $400 to $450 million. release Feb 4, 2025
This guidance reflects tariff levels in effect as of the end of July 2025. … Capital expenditures for the full year are expected to be approximately $400 to $425 million. release Aug 1, 2025
Capital expenditures for the full year are expected to be approximately $400 to $425 million. release Nov 4, 2025
Diluted EPS
Fiscal 2025 (ended Dec 31, 2025)
Given $10.93 to $11.63 release May 6, 2025
Raised $11.25 to $11.75 release Aug 1, 2025
Lowered $11.11 to $11.31 release Nov 4, 2025
$11.18
10-K filed 2026-02-17
Within the range
The company's words
The Company expects its full-year 2025 reported EPS to be in the range of $10.93 to $11.63 and adjusted EPS to be in the range of $10.90 to $11.60. release May 6, 2025
The Company expects its full-year 2025 reported EPS to be in the range of $11.25 to $11.75 and adjusted EPS to be in the range of $11.10 to $11.60. release Aug 1, 2025
Adjusting full-year guidance for reported EPS to be in the range of $11.11 to $11.31 and adjusted EPS to be in the range of $11.10 to $11.30 release Nov 4, 2025
Diluted EPS (company-defined)
Fiscal 2025 (ended Dec 31, 2025)
Given $10.90 to $11.60 release May 6, 2025
Raised $11.10 to $11.60 release Aug 1, 2025
Lowered $11.10 to $11.30 release Nov 4, 2025
– No standard number
The company's words
Updated Full-Year 2025 Outlook … The Company expects its full-year 2025 reported EPS to be in the range of $10.93 to $11.63 and adjusted EPS to be in the range of $10.90 to $11.60. release May 6, 2025
Updated Third Quarter and Full-Year 2025 Outlook … The Company expects its full-year 2025 reported EPS to be in the range of $11.25 to $11.75 and adjusted EPS to be in the range of $11.10 to $11.60. release Aug 1, 2025
Adjusting full-year guidance for reported EPS to be in the range of $11.11 to $11.31 and adjusted EPS to be in the range of $11.10 to $11.30 release Nov 4, 2025
Capital expenditures
Fiscal 2024 (ended Dec 31, 2024)
Given $340.00M release Feb 6, 2024
Kept $340.00M release May 8, 2024
Kept $340.00M release Aug 6, 2024
Lowered $310.00M to $330.00M release Nov 5, 2024
$301.00M
10-K filed 2025-02-20
Below the range
The company's words
2024 Full-Year Outlook … Capital expenditures for the full year are expected to be approximately $340 million. release Feb 6, 2024
Updated Second Quarter and Full-Year 2024 Outlook … Capital expenditures for the full year are still expected to be approximately $340 million. release May 8, 2024
Updated Third Quarter and Full-Year 2024 Outlook … Capital expenditures for the full year are still expected to be approximately $340 million. release Aug 6, 2024
Updated Full-Year 2024 Outlook … Capital expenditures for the full year are expected to be approximately $310 to $330 million. release Nov 5, 2024
Diluted EPS
Fiscal 2024 (ended Dec 31, 2024)
Given $10.20 to $11.15 release Feb 6, 2024
Narrowed $10.35 to $11.00 release May 8, 2024
Lowered $10.20 to $10.70 release Aug 6, 2024
Raised $10.60 to $10.90 release Nov 5, 2024
$9.71
10-K filed 2025-02-20
Below the range
The company's words
The Company expects its full-year 2024 outlook for reported EPS to be in the range of $10.20 to $11.15 and adjusted EPS to be in the range of $9.15 to $9.85, reflecting the impact of the S. Korea business divestiture release Feb 6, 2024
The Company now expects its full-year 2024 reported EPS to be in the range of $10.35 to $11.00, which includes the impact of the gain on the divestiture of the South Korea business completed on February 1, 2024, and adjusted EPS to be in the range of $9.20 to $9.85. release May 8, 2024
The Company now expects its full-year 2024 reported EPS to be in the range of $10.20 to $10.70, which includes the impact of the gain on the sale of the South Korea business completed on February 1, 2024. release Aug 6, 2024
The Company expects its full-year 2024 reported EPS to be in the range of $10.60 to $10.90, which includes the impact of the gain on the sale of our South Korea business. release Nov 5, 2024
Diluted EPS (company-defined)
Fiscal 2024 (ended Dec 31, 2024)
Given $9.15 to $9.85 release Feb 6, 2024
Raised $9.20 to $9.85 release May 8, 2024
Raised $10.35 to $10.65 release Nov 5, 2024
– No standard number
The company's words
The Company expects its full-year 2024 outlook for reported EPS to be in the range of $10.20 to $11.15 and adjusted EPS to be in the range of $9.15 to $9.85, reflecting the impact of the S. Korea business divestiture release Feb 6, 2024
Updated Second Quarter and Full-Year 2024 Outlook … The Company now expects its full-year 2024 reported EPS to be in the range of $10.35 to $11.00, which includes the impact of the gain on the divestiture of the South Korea business completed on February 1, 2024, and adjusted EPS to be in the range of $9.20 to $9.85. release May 8, 2024
Updated Full-Year 2024 Outlook … The Company now anticipates adjusted EPS to be in the range of $10.35 to $10.65. release Nov 5, 2024
Diluted EPS (company-defined)
Q3 of fiscal 2024
Given $9.70 to $10.20 release Aug 6, 2024
– No standard number
The company's words
Updated Third Quarter and Full-Year 2024 Outlook … The Company anticipates adjusted EPS to be in the range of $9.70 to $10.20. release Aug 6, 2024

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-06), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INGR/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.